Tirzepatide emerges a groundbreaking pharmaceutical agent for individuals struggling type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://robertfwwt055656.blogrenanda.com/47421886/tirzepatide-a-novel-glp-1-and-gip-receptor-agonist